Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 38
Selected: 0
NCT IDTitle
NCT05283395Rocklatan® Evaluation
NCT03844945Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
NCT02406287A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers
NCT02558374Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT05497479Study Evaluating Techniques for Measuring Tear Production
NCT01731002Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
NCT03284853Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
NCT01789736A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
NCT0133097924-hour Efficacy of AR-12286
NCT04498169A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
NCT03739593Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
NCT04620135Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT04498182A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT02558400Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT02674854Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT00902200A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
NCT04401982Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
NCT02207491Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT04064918Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity
NCT01528787Study of AR-13324 in Patients With Elevated Intraocular Pressure
NCT02246764Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01474135AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
NCT01699464A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
NCT03233308Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT00523250Ocular Hypotensive Efficacy of AR-102
NCT01060579Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
NCT05360966Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
NCT03835884A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
NCT02057575Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
NCT01302249AR-12286 in Combination With Latanoprost
NCT05285644Study Evaluating the Safety and Efficacy of AR-15512
NCT01997879Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers
NCT03310580Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
NCT02874846Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution
NCT02207621Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
NCT03808688Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
NCT01250197Formulation Comparison in Normal Volunteers
NCT05493111A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512